Self-hypnosis Training for Chronic Pain Management
Recruiting now NCT06279650
Run by Ciusss de L'Est de l'Île de Montréal · for 18 and older · All sexes
What this study is about
Title: Self-hypnosis training in chronic pain management: A pilot study Our primary objective concerns the effect of hypnosis intervention on change in 24h pain between T0 (pre-intervention) and T4 (3-month follow-up). The secondary objectives concern the effects of the intervention on (i) change in 24h pain between T0 and T5 (6-month follow-up), (ii) changes from T0 in measures of the functional impact of pain, (iii) changes from T0 in anxiety-depression scores and (iv) changes from T0 in quality of life. The study design is a Randomized efficacy pilot study. The study focuses on patients practicing self-hypnosis within HMR groups. The study population is pain clinic patients. The sample size is 60 pain clinic patients. Study duration: February 2024 - December 2024. Center responsible for the study: Centre de Recherche de l'Hôpital Maisonneuve-Rosemont (CR-HMR) - CEMTL, Montreal, Quebec, Canada. Adverse events: none expected.
Who can join (things the study team will check)
✅ You may be able to join if…
- be 18 years of age or older;
- have received one of the above diagnoses, confirmed by medical record review or physician confirmation;
- report pain that has been present for at least 3 months;
- have a pain intensity over the last 24 hours (24h pain) of at least 4 on a Numerical Rating Scale (NRS) from 0 to 10 at baseline;
- be able to read, speak and understand French;
- have Internet access and be able to participate in a telepractice intervention group and complete online questionnaires.
🚫 You may not be able to join if…
- have deafness and/or severe cognitive impairment that may impair communication;
- have current or recent psychiatric instability (e.g., active suicidal ideation, active delusional or psychotic thoughts) that could interfere with participation, as assessed by a clinical psychologist.
Where this trial is running
- 5415 Bd de l'Assomption, Montreal, Quebec, Canada
Who to contact
David Ogez · 514 609-4391 · david.ogez@umontreal.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT06279650.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.